Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement

BMEDvsBBHETF Comparison

ETF 1
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
+0.13%
VS
ETF 2
BBH

VanEck Biotech ETF

This fund is part of
US Health Care
+0.95%

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. VanEck Biotech ETF (BBH) is part of the US Health Care segment. BMED's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, BBH's top sector exposures are Healthcare. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.35% for BBH. BMED is up 13.51% year-to-date (YTD) with +$5M in YTD flows. BBH performs better with 28.31% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of BMED and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BMED vs BBH performance and flow charts

Performance

05101520%Aug 3Aug 10Aug 17Aug 24Aug 31

Cumulative Flows

0 M2 M4 M6 M8 M10 MAug 3Aug 10Aug 17Aug 24Aug 31

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/02/2026
1M3MYTD1Y3Y5Y
Perf.
BMED
BBH
+11.08%+18.82%
+23.21%+33.60%
+13.51%+28.31%
+30.70%+46.56%
+44.72%+52.30%
+10.62%+13.07%
Flows
BMED
BBH
+$1M+$10M
+$1M+$9M
+$5M+$2M
+$7M-$21M
+$7M-$154M
+$6M-$135M
Volatility and drawdown
3M1Y3Y5Y
Volatility
BMED
BBH
+21.61%+27.08%
+17.42%+21.65%
+16.62%+20.12%
+18.01%+21.77%
Max drawdown
BMED
BBH
-4.62%-5.29%
-14.71%-10.54%
-19.76%-22.78%
-33.96%-39.56%
Max drawdown duration
BMED
BBH
32d30d
196d150d
237d440d
1586d1795d
Trading data

Create an account to view trading data

Join for free
BMED
BBH
Last sale
9/2/2026 at 1:30 PM
$34.28
$242.42
Previous close
09/02/2026
$33.91
$242.79
Consolidated volume
09/02/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
BMED
BBH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/2/2026 at 1:30 PM
Live
Closed
BMED
BBH
Last price
$34.28
$242.42
1D performance
+1.10%
-0.15%
AuM$13.71 M$482.23 M
E/R0.77%0.35%
Characteristics
BMED
BBH
Management strategyActivePassive
ProvideriSharesVanEck
Benchmark-MVIS US Listed Biotech 25 Index
N° of holdings5324
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 29, 2020December 20, 2011
ESGNoNo
Advertisement
Exposure

Countries

BMED
USA
86.04%
Other
13.96%
BBH
USA
87.55%
Other
12.45%

Sectors

BMED
Healthcare
95.69%
Other
4.31%
BBH
Healthcare
100%
Advertisement

Diversification

BMED

Total weight of top 15 holdings out of 15

56.15%
BBH

Total weight of top 15 holdings out of 15

85.32%

Top 15 holdings

Data as of July 31, 2026
BMED
Merck & Co., Inc.
5.85%
Gilead Sciences, Inc.
4.87%
Johnson & Johnson
4.45%
Edwards Lifesciences Corp.
4.43%
Thermo Fisher Scientific, Inc.
4.17%
Charles River Laboratories International, Inc.
3.72%
Danaher Corp.
3.63%
Biogen, Inc.
3.58%
Waters Corp.
3.50%
AbbVie, Inc.
3.50%
Mettler-Toledo International, Inc.
3.37%
Moderna, Inc.
3.07%
Vertex Pharmaceuticals, Inc.
2.96%
BlackRock Cash Funds - Treasury
2.58%
Amgen, Inc.
2.49%
BBH
Amgen, Inc.
15.97%
Gilead Sciences, Inc.
12.99%
Vertex Pharmaceuticals, Inc.
8.62%
Regeneron Pharmaceuticals, Inc.
7.18%
Revolution Medicines, Inc.
5.29%
IQVIA Holdings, Inc.
5.18%
Natera, Inc.
4.77%
argenx SE
4.58%
Illumina, Inc.
3.62%
Biogen, Inc.
3.41%
BeOne Medicines Ltd.
3.10%
Moderna, Inc.
2.72%
United Therapeutics Corp.
2.68%
Incyte Corp.
2.65%
Alnylam Pharmaceuticals, Inc.
2.56%
Frequently asked questions about BMED and BBH

How have the BMED and BBH ETFs performed in 2026?

As of September 2, 2026, BMED is up 13.51% year-to-date (YTD), while BBH has returned 28.31%. That puts BBH better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or BBH?

Year-to-date, the BMED ETF saw +$5M in flows, compared to +$2M for BBH.

Which ETF is more volatile: BMED or BBH?

Over the past year, BMED had a volatility of 17.42%, while BBH experienced 21.65%.

Which ETF is bigger: BMED or BBH?

As of September 2, 2026, BMED holds $13.71 M in assets under management (AUM), while BBH manages $482.23 M.

What sectors do the BMED and BBH ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, BBH focuses on Healthcare.

What are the top holdings of the BMED ETF and BBH ETF?

BMED top holdings include Merck & Co., Inc., Gilead Sciences, Inc. and Johnson & Johnson. BBH holds in its top three: Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc..

Which ETF is more diversified: BMED or BBH?

BMED holds 56 securities with 56.15% of its assets in the top 15. BBH has 24 securities and a top 15 weight of 85.32%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder